Press releases

A team of cyclists from Sobi™ have cycled from Bonn to Hamburg from 29 August – 1 September to help raise funds for people with haemophilia as well as awareness about the condition.

The 2019 Liberate Life Bike Ride is the fourth Sobi charity ride to raise funds for the...

09/02/2019 - 15:30

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has entered into an agreement to sell a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) to AstraZeneca for a total cash consideration of USD 95 M. A PRV entitles the holder to FDA priority review...

08/22/2019 - 08:00

Following approvals from relevant competition authorities Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has completed the acquisition of the newly established company owning emapalumab and related assets, as announced on 12 June 2019. The acquisition means that...

07/18/2019 - 12:10

Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces its results for the second quarter 2019. Total revenue was SEK 3,163 M (2,289), with 38 per cent revenue growth in the quarter compared with Q2 2018 (32 per cent at constant exchange rates (CER)). Organic growth...

07/17/2019 - 08:00
Regulatory

The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi™) on 9 May 2019, resolved – for the purpose of ensuring that the company can fulfil its commitments under the long-term incentive programme resolved by the Annual General Meeting – on a directed...

07/16/2019 - 18:30
Regulatory

Press contacts

Subscribe to our press releases and financial reports